UroGen Reports Final Five-Year Olympus Study Follow-Up Results for JELMYTO
UroGen Pharma announced publication of final results from the Olympus long-term follow-up study in patients with low-grade upper tract urothelial cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.